- Home
- SPHL vs LNSR Comparison
SPHL vs LNSR Comparison
Compare SPHL & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPHL
- LNSR
- Stock Information
- Founded
- SPHL 2002
- LNSR 2004
- Country
- SPHL Singapore
- LNSR United States
- Employees
- SPHL N/A
- LNSR N/A
- Industry
- SPHL Homebuilding
- LNSR Medical Electronics
- Sector
- SPHL Consumer Discretionary
- LNSR Health Care
- Exchange
- SPHL Nasdaq
- LNSR Nasdaq
- Market Cap
- SPHL 54.5M
- LNSR 63.4M
- IPO Year
- SPHL 2024
- LNSR N/A
- Fundamental
- Price
- SPHL $5.76
- LNSR $7.83
- Analyst Decision
- SPHL
- LNSR
- Analyst Count
- SPHL 0
- LNSR 0
- Target Price
- SPHL N/A
- LNSR N/A
- AVG Volume (30 Days)
- SPHL 95.6K
- LNSR 47.6K
- Earning Date
- SPHL 12-24-2024
- LNSR 11-07-2024
- Dividend Yield
- SPHL N/A
- LNSR N/A
- EPS Growth
- SPHL 413.11
- LNSR N/A
- EPS
- SPHL 0.09
- LNSR N/A
- Revenue
- SPHL $11,020,429.00
- LNSR $48,868,000.00
- Revenue This Year
- SPHL N/A
- LNSR $25.07
- Revenue Next Year
- SPHL N/A
- LNSR $24.95
- P/E Ratio
- SPHL $65.84
- LNSR N/A
- Revenue Growth
- SPHL 112.84
- LNSR 21.29
- 52 Week Low
- SPHL $3.82
- LNSR $2.33
- 52 Week High
- SPHL $5.95
- LNSR $8.17
- Technical
- Relative Strength Index (RSI)
- SPHL N/A
- LNSR 57.90
- Support Level
- SPHL N/A
- LNSR $7.13
- Resistance Level
- SPHL N/A
- LNSR $7.98
- Average True Range (ATR)
- SPHL 0.00
- LNSR 0.47
- MACD
- SPHL 0.00
- LNSR -0.06
- Stochastic Oscillator
- SPHL 0.00
- LNSR 63.33
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.